Pharma & Healthcare
Global Knee Osteoarthritis Treatment Market Research Report 2025
- Jul 28, 25
- ID: 409196
- Pages: 82
- Figures: 88
- Views: 6
The global market for Knee Osteoarthritis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Knee Osteoarthritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Knee Osteoarthritis Treatment.
The Knee Osteoarthritis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Knee Osteoarthritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Knee Osteoarthritis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bioventus
AVM Biotechnology
Anika Therapeutics
Flexion Therapeutics
OrthoTrophix
Sanofi
Horizon Therapeutics
Johnson and Johnson
GlaxoSmithKline
Bayer
Abbott
Pfizer
Eli Lilly
Segment by Type
Non-surgical Treatment
Surgical Treatment
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Knee Osteoarthritis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Knee Osteoarthritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Knee Osteoarthritis Treatment.
The Knee Osteoarthritis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Knee Osteoarthritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Knee Osteoarthritis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bioventus
AVM Biotechnology
Anika Therapeutics
Flexion Therapeutics
OrthoTrophix
Sanofi
Horizon Therapeutics
Johnson and Johnson
GlaxoSmithKline
Bayer
Abbott
Pfizer
Eli Lilly
Segment by Type
Non-surgical Treatment
Surgical Treatment
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Knee Osteoarthritis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-surgical Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Knee Osteoarthritis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Knee Osteoarthritis Treatment Market Perspective (2020-2031)
2.2 Global Knee Osteoarthritis Treatment Growth Trends by Region
2.2.1 Global Knee Osteoarthritis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Knee Osteoarthritis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Knee Osteoarthritis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Knee Osteoarthritis Treatment Market Dynamics
2.3.1 Knee Osteoarthritis Treatment Industry Trends
2.3.2 Knee Osteoarthritis Treatment Market Drivers
2.3.3 Knee Osteoarthritis Treatment Market Challenges
2.3.4 Knee Osteoarthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Knee Osteoarthritis Treatment Players by Revenue
3.1.1 Global Top Knee Osteoarthritis Treatment Players by Revenue (2020-2025)
3.1.2 Global Knee Osteoarthritis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Knee Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Knee Osteoarthritis Treatment Revenue
3.4 Global Knee Osteoarthritis Treatment Market Concentration Ratio
3.4.1 Global Knee Osteoarthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Knee Osteoarthritis Treatment Revenue in 2024
3.5 Global Key Players of Knee Osteoarthritis Treatment Head office and Area Served
3.6 Global Key Players of Knee Osteoarthritis Treatment, Product and Application
3.7 Global Key Players of Knee Osteoarthritis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Knee Osteoarthritis Treatment Breakdown Data by Type
4.1 Global Knee Osteoarthritis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2026-2031)
5 Knee Osteoarthritis Treatment Breakdown Data by Application
5.1 Global Knee Osteoarthritis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Knee Osteoarthritis Treatment Market Size (2020-2031)
6.2 North America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Knee Osteoarthritis Treatment Market Size by Country (2020-2025)
6.4 North America Knee Osteoarthritis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Knee Osteoarthritis Treatment Market Size (2020-2031)
7.2 Europe Knee Osteoarthritis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Knee Osteoarthritis Treatment Market Size by Country (2020-2025)
7.4 Europe Knee Osteoarthritis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Knee Osteoarthritis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Knee Osteoarthritis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Knee Osteoarthritis Treatment Market Size (2020-2031)
9.2 Latin America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Knee Osteoarthritis Treatment Market Size by Country (2020-2025)
9.4 Latin America Knee Osteoarthritis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Knee Osteoarthritis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Knee Osteoarthritis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bioventus
11.1.1 Bioventus Company Details
11.1.2 Bioventus Business Overview
11.1.3 Bioventus Knee Osteoarthritis Treatment Introduction
11.1.4 Bioventus Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.1.5 Bioventus Recent Development
11.2 AVM Biotechnology
11.2.1 AVM Biotechnology Company Details
11.2.2 AVM Biotechnology Business Overview
11.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Introduction
11.2.4 AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.2.5 AVM Biotechnology Recent Development
11.3 Anika Therapeutics
11.3.1 Anika Therapeutics Company Details
11.3.2 Anika Therapeutics Business Overview
11.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Introduction
11.3.4 Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.3.5 Anika Therapeutics Recent Development
11.4 Flexion Therapeutics
11.4.1 Flexion Therapeutics Company Details
11.4.2 Flexion Therapeutics Business Overview
11.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Introduction
11.4.4 Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.4.5 Flexion Therapeutics Recent Development
11.5 OrthoTrophix
11.5.1 OrthoTrophix Company Details
11.5.2 OrthoTrophix Business Overview
11.5.3 OrthoTrophix Knee Osteoarthritis Treatment Introduction
11.5.4 OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.5.5 OrthoTrophix Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Knee Osteoarthritis Treatment Introduction
11.6.4 Sanofi Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Horizon Therapeutics
11.7.1 Horizon Therapeutics Company Details
11.7.2 Horizon Therapeutics Business Overview
11.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Introduction
11.7.4 Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.7.5 Horizon Therapeutics Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Introduction
11.8.4 Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.8.5 Johnson and Johnson Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Introduction
11.9.4 GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.9.5 GlaxoSmithKline Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Knee Osteoarthritis Treatment Introduction
11.10.4 Bayer Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.10.5 Bayer Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Knee Osteoarthritis Treatment Introduction
11.11.4 Abbott Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.11.5 Abbott Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Knee Osteoarthritis Treatment Introduction
11.12.4 Pfizer Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Knee Osteoarthritis Treatment Introduction
11.13.4 Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.13.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-surgical Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Knee Osteoarthritis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Knee Osteoarthritis Treatment Market Perspective (2020-2031)
2.2 Global Knee Osteoarthritis Treatment Growth Trends by Region
2.2.1 Global Knee Osteoarthritis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Knee Osteoarthritis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Knee Osteoarthritis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Knee Osteoarthritis Treatment Market Dynamics
2.3.1 Knee Osteoarthritis Treatment Industry Trends
2.3.2 Knee Osteoarthritis Treatment Market Drivers
2.3.3 Knee Osteoarthritis Treatment Market Challenges
2.3.4 Knee Osteoarthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Knee Osteoarthritis Treatment Players by Revenue
3.1.1 Global Top Knee Osteoarthritis Treatment Players by Revenue (2020-2025)
3.1.2 Global Knee Osteoarthritis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Knee Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Knee Osteoarthritis Treatment Revenue
3.4 Global Knee Osteoarthritis Treatment Market Concentration Ratio
3.4.1 Global Knee Osteoarthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Knee Osteoarthritis Treatment Revenue in 2024
3.5 Global Key Players of Knee Osteoarthritis Treatment Head office and Area Served
3.6 Global Key Players of Knee Osteoarthritis Treatment, Product and Application
3.7 Global Key Players of Knee Osteoarthritis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Knee Osteoarthritis Treatment Breakdown Data by Type
4.1 Global Knee Osteoarthritis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2026-2031)
5 Knee Osteoarthritis Treatment Breakdown Data by Application
5.1 Global Knee Osteoarthritis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Knee Osteoarthritis Treatment Market Size (2020-2031)
6.2 North America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Knee Osteoarthritis Treatment Market Size by Country (2020-2025)
6.4 North America Knee Osteoarthritis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Knee Osteoarthritis Treatment Market Size (2020-2031)
7.2 Europe Knee Osteoarthritis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Knee Osteoarthritis Treatment Market Size by Country (2020-2025)
7.4 Europe Knee Osteoarthritis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Knee Osteoarthritis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Knee Osteoarthritis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Knee Osteoarthritis Treatment Market Size (2020-2031)
9.2 Latin America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Knee Osteoarthritis Treatment Market Size by Country (2020-2025)
9.4 Latin America Knee Osteoarthritis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Knee Osteoarthritis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Knee Osteoarthritis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bioventus
11.1.1 Bioventus Company Details
11.1.2 Bioventus Business Overview
11.1.3 Bioventus Knee Osteoarthritis Treatment Introduction
11.1.4 Bioventus Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.1.5 Bioventus Recent Development
11.2 AVM Biotechnology
11.2.1 AVM Biotechnology Company Details
11.2.2 AVM Biotechnology Business Overview
11.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Introduction
11.2.4 AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.2.5 AVM Biotechnology Recent Development
11.3 Anika Therapeutics
11.3.1 Anika Therapeutics Company Details
11.3.2 Anika Therapeutics Business Overview
11.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Introduction
11.3.4 Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.3.5 Anika Therapeutics Recent Development
11.4 Flexion Therapeutics
11.4.1 Flexion Therapeutics Company Details
11.4.2 Flexion Therapeutics Business Overview
11.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Introduction
11.4.4 Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.4.5 Flexion Therapeutics Recent Development
11.5 OrthoTrophix
11.5.1 OrthoTrophix Company Details
11.5.2 OrthoTrophix Business Overview
11.5.3 OrthoTrophix Knee Osteoarthritis Treatment Introduction
11.5.4 OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.5.5 OrthoTrophix Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Knee Osteoarthritis Treatment Introduction
11.6.4 Sanofi Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Horizon Therapeutics
11.7.1 Horizon Therapeutics Company Details
11.7.2 Horizon Therapeutics Business Overview
11.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Introduction
11.7.4 Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.7.5 Horizon Therapeutics Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Introduction
11.8.4 Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.8.5 Johnson and Johnson Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Introduction
11.9.4 GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.9.5 GlaxoSmithKline Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Knee Osteoarthritis Treatment Introduction
11.10.4 Bayer Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.10.5 Bayer Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Knee Osteoarthritis Treatment Introduction
11.11.4 Abbott Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.11.5 Abbott Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Knee Osteoarthritis Treatment Introduction
11.12.4 Pfizer Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Knee Osteoarthritis Treatment Introduction
11.13.4 Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2020-2025)
11.13.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-surgical Treatment
Table 3. Key Players of Surgical Treatment
Table 4. Global Knee Osteoarthritis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Knee Osteoarthritis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Knee Osteoarthritis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Knee Osteoarthritis Treatment Market Share by Region (2020-2025)
Table 8. Global Knee Osteoarthritis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Knee Osteoarthritis Treatment Market Share by Region (2026-2031)
Table 10. Knee Osteoarthritis Treatment Market Trends
Table 11. Knee Osteoarthritis Treatment Market Drivers
Table 12. Knee Osteoarthritis Treatment Market Challenges
Table 13. Knee Osteoarthritis Treatment Market Restraints
Table 14. Global Knee Osteoarthritis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Knee Osteoarthritis Treatment Market Share by Players (2020-2025)
Table 16. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2024)
Table 17. Ranking of Global Top Knee Osteoarthritis Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Knee Osteoarthritis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Knee Osteoarthritis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Knee Osteoarthritis Treatment, Product and Application
Table 21. Global Key Players of Knee Osteoarthritis Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Knee Osteoarthritis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Knee Osteoarthritis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Knee Osteoarthritis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Knee Osteoarthritis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Knee Osteoarthritis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Knee Osteoarthritis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Knee Osteoarthritis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Knee Osteoarthritis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Knee Osteoarthritis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bioventus Company Details
Table 47. Bioventus Business Overview
Table 48. Bioventus Knee Osteoarthritis Treatment Product
Table 49. Bioventus Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 50. Bioventus Recent Development
Table 51. AVM Biotechnology Company Details
Table 52. AVM Biotechnology Business Overview
Table 53. AVM Biotechnology Knee Osteoarthritis Treatment Product
Table 54. AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 55. AVM Biotechnology Recent Development
Table 56. Anika Therapeutics Company Details
Table 57. Anika Therapeutics Business Overview
Table 58. Anika Therapeutics Knee Osteoarthritis Treatment Product
Table 59. Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 60. Anika Therapeutics Recent Development
Table 61. Flexion Therapeutics Company Details
Table 62. Flexion Therapeutics Business Overview
Table 63. Flexion Therapeutics Knee Osteoarthritis Treatment Product
Table 64. Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 65. Flexion Therapeutics Recent Development
Table 66. OrthoTrophix Company Details
Table 67. OrthoTrophix Business Overview
Table 68. OrthoTrophix Knee Osteoarthritis Treatment Product
Table 69. OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 70. OrthoTrophix Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Knee Osteoarthritis Treatment Product
Table 74. Sanofi Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Horizon Therapeutics Company Details
Table 77. Horizon Therapeutics Business Overview
Table 78. Horizon Therapeutics Knee Osteoarthritis Treatment Product
Table 79. Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 80. Horizon Therapeutics Recent Development
Table 81. Johnson and Johnson Company Details
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Knee Osteoarthritis Treatment Product
Table 84. Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 85. Johnson and Johnson Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Knee Osteoarthritis Treatment Product
Table 89. GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Knee Osteoarthritis Treatment Product
Table 94. Bayer Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. Abbott Company Details
Table 97. Abbott Business Overview
Table 98. Abbott Knee Osteoarthritis Treatment Product
Table 99. Abbott Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 100. Abbott Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Knee Osteoarthritis Treatment Product
Table 104. Pfizer Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Eli Lilly Company Details
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Knee Osteoarthritis Treatment Product
Table 109. Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Knee Osteoarthritis Treatment Picture
Figure 2. Global Knee Osteoarthritis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Knee Osteoarthritis Treatment Market Share by Type: 2024 VS 2031
Figure 4. Non-surgical Treatment Features
Figure 5. Surgical Treatment Features
Figure 6. Global Knee Osteoarthritis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Knee Osteoarthritis Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Knee Osteoarthritis Treatment Report Years Considered
Figure 13. Global Knee Osteoarthritis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Knee Osteoarthritis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Knee Osteoarthritis Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Knee Osteoarthritis Treatment Market Share by Players in 2024
Figure 17. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Knee Osteoarthritis Treatment Revenue in 2024
Figure 19. North America Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Knee Osteoarthritis Treatment Market Share by Country (2020-2031)
Figure 21. United States Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Knee Osteoarthritis Treatment Market Share by Country (2020-2031)
Figure 25. Germany Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Knee Osteoarthritis Treatment Market Share by Region (2020-2031)
Figure 33. China Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Knee Osteoarthritis Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Knee Osteoarthritis Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Bioventus Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 49. AVM Biotechnology Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 50. Anika Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 51. Flexion Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 52. OrthoTrophix Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 54. Horizon Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 55. Johnson and Johnson Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 57. Bayer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 58. Abbott Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 59. Pfizer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 60. Eli Lilly Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-surgical Treatment
Table 3. Key Players of Surgical Treatment
Table 4. Global Knee Osteoarthritis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Knee Osteoarthritis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Knee Osteoarthritis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Knee Osteoarthritis Treatment Market Share by Region (2020-2025)
Table 8. Global Knee Osteoarthritis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Knee Osteoarthritis Treatment Market Share by Region (2026-2031)
Table 10. Knee Osteoarthritis Treatment Market Trends
Table 11. Knee Osteoarthritis Treatment Market Drivers
Table 12. Knee Osteoarthritis Treatment Market Challenges
Table 13. Knee Osteoarthritis Treatment Market Restraints
Table 14. Global Knee Osteoarthritis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Knee Osteoarthritis Treatment Market Share by Players (2020-2025)
Table 16. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2024)
Table 17. Ranking of Global Top Knee Osteoarthritis Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Knee Osteoarthritis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Knee Osteoarthritis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Knee Osteoarthritis Treatment, Product and Application
Table 21. Global Key Players of Knee Osteoarthritis Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Knee Osteoarthritis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Knee Osteoarthritis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Knee Osteoarthritis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Knee Osteoarthritis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Knee Osteoarthritis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Knee Osteoarthritis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Knee Osteoarthritis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Knee Osteoarthritis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Knee Osteoarthritis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bioventus Company Details
Table 47. Bioventus Business Overview
Table 48. Bioventus Knee Osteoarthritis Treatment Product
Table 49. Bioventus Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 50. Bioventus Recent Development
Table 51. AVM Biotechnology Company Details
Table 52. AVM Biotechnology Business Overview
Table 53. AVM Biotechnology Knee Osteoarthritis Treatment Product
Table 54. AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 55. AVM Biotechnology Recent Development
Table 56. Anika Therapeutics Company Details
Table 57. Anika Therapeutics Business Overview
Table 58. Anika Therapeutics Knee Osteoarthritis Treatment Product
Table 59. Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 60. Anika Therapeutics Recent Development
Table 61. Flexion Therapeutics Company Details
Table 62. Flexion Therapeutics Business Overview
Table 63. Flexion Therapeutics Knee Osteoarthritis Treatment Product
Table 64. Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 65. Flexion Therapeutics Recent Development
Table 66. OrthoTrophix Company Details
Table 67. OrthoTrophix Business Overview
Table 68. OrthoTrophix Knee Osteoarthritis Treatment Product
Table 69. OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 70. OrthoTrophix Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Knee Osteoarthritis Treatment Product
Table 74. Sanofi Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Horizon Therapeutics Company Details
Table 77. Horizon Therapeutics Business Overview
Table 78. Horizon Therapeutics Knee Osteoarthritis Treatment Product
Table 79. Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 80. Horizon Therapeutics Recent Development
Table 81. Johnson and Johnson Company Details
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Knee Osteoarthritis Treatment Product
Table 84. Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 85. Johnson and Johnson Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Knee Osteoarthritis Treatment Product
Table 89. GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Knee Osteoarthritis Treatment Product
Table 94. Bayer Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. Abbott Company Details
Table 97. Abbott Business Overview
Table 98. Abbott Knee Osteoarthritis Treatment Product
Table 99. Abbott Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 100. Abbott Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Knee Osteoarthritis Treatment Product
Table 104. Pfizer Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Eli Lilly Company Details
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Knee Osteoarthritis Treatment Product
Table 109. Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2020-2025) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Knee Osteoarthritis Treatment Picture
Figure 2. Global Knee Osteoarthritis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Knee Osteoarthritis Treatment Market Share by Type: 2024 VS 2031
Figure 4. Non-surgical Treatment Features
Figure 5. Surgical Treatment Features
Figure 6. Global Knee Osteoarthritis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Knee Osteoarthritis Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Knee Osteoarthritis Treatment Report Years Considered
Figure 13. Global Knee Osteoarthritis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Knee Osteoarthritis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Knee Osteoarthritis Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Knee Osteoarthritis Treatment Market Share by Players in 2024
Figure 17. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Knee Osteoarthritis Treatment Revenue in 2024
Figure 19. North America Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Knee Osteoarthritis Treatment Market Share by Country (2020-2031)
Figure 21. United States Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Knee Osteoarthritis Treatment Market Share by Country (2020-2031)
Figure 25. Germany Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Knee Osteoarthritis Treatment Market Share by Region (2020-2031)
Figure 33. China Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Knee Osteoarthritis Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Knee Osteoarthritis Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Knee Osteoarthritis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Bioventus Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 49. AVM Biotechnology Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 50. Anika Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 51. Flexion Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 52. OrthoTrophix Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 54. Horizon Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 55. Johnson and Johnson Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 57. Bayer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 58. Abbott Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 59. Pfizer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 60. Eli Lilly Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232